Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

R.A. de Boer*, S. Heymans, J. Backs, L. Carrier, A.J.S. Coats, S. Dimmeler, T. Eschenhagen, G. Filippatos, L. Gepstein, J.S. Hulot, R. Knoll, C. Kupatt, W.A. Linke, C.E. Seidman, C.G. Tocchetti, J. van der Velden, R. Walsh, P.M. Seferovic, T. Thum

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science